TWIST1 and cancer: Furthermore, the finding that Twist1 plays an essential role in the pathogenesis of pathological fibrosis indicates that DHR, a compound inhibiting Twist1 expression in fibroblasts, can be considered a potential therapeutic agent for fibrotic diseases in addition to modifying the cancer microenvironment.